Results 151 to 160 of about 30,028 (235)

Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine

open access: yes
We studied the effects of the bile acid sequestrant cholestyramine, alone and in combination with the experimental agent compactin (ML-236B), a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on serum levels of lipoproteins in ...
Mabuchi, Hiroshi   +7 more
core   +1 more source

Real-World Experience from Türkiye: Genetic and Therapeutic Insights in Pediatric Heterozygous Familial Hypercholesterolemia [PDF]

open access: yesJ Clin Res Pediatr Endocrinol
Yazıcı H   +12 more
europepmc   +1 more source

Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia. [PDF]

open access: yesBiomedicines, 2022
Curia MC   +10 more
europepmc   +1 more source

Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins. [PDF]

open access: yesJ Clin Med, 2021
Marco-Benedí V   +6 more
europepmc   +1 more source

Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study. [PDF]

open access: yesEBioMedicine, 2021
Gallo A   +16 more
europepmc   +1 more source

Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study. [PDF]

open access: yesCardiovasc Diabetol
González-Lleó AM   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy